Cited by 697Histone Deacetylase Inhibitors ResearchGenomics and Chromatin DynamicsEpigenetics and DNA Methylation

The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.

HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics

Gallinari, Paola, Marco, Stefania Di, Jones, Phillip, Pallaoro, Michele, Steinkühler, Christian·2007·Cell Research

Open this paper in CoChat — free account

Abstract

Histone deacetylases (HDACs) and histone acetyl transferases (HATs) are two counteracting enzyme families whose enzymatic activity controls the acetylation state of protein lysine residues, notably those contained in the N-terminal extensions of the core histones. Acetylation of histones affects gene expression through its influence on chromatin conformation. In addition, several non-histone proteins are regulated in their stability or biological function by the acetylation state of specific lysine residues. HDACs intervene in a multitude of biological processes and are part of a multiprotein family in which each member has its specialized functions. In addition, HDAC activity is tightly controlled through targeted recruitment, protein-protein interactions and post-translational modifications. Control of cell cycle progression, cell survival and differentiation are among the most important roles of these enzymes. Since these processes are affected by malignant transformation, HDAC inhibitors were developed as antineoplastic drugs and are showing encouraging efficacy in cancer patients.

Integrity signals

Registry

Crossref · 10.1038/sj.cr.7310149

Cites

165 of 165 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Translating the Histone Code
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
DNA methylation and human disease
Robertson, K. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1655 · Cited by 2,864
ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS
Allfrey, V. G., Faulkner, R. D., & Mirsky, A. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.786 · Cited by 2,788
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,234
The diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,157
Histone Acetyltransferases
Dent, S., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,906

Flagged first, then by citations

Show all 165 references

Research works printed but not linked: 1

Vaisburg A . Discovery and development of MGCD0103 – an orally active HDAC inhibitor in human clinical trials. XIXth International Symposium on Medical Chemistry, Istanbul, Aug 29-Sep 2, 2006.

Sorted by citations

Items 101–200 of 697

Identification of novel modulators of mitochondrial function by a genome-wide RNAi screen in Drosophila melanogasterPreprint
Chen, J., Shi, X., Padmanabhan, R., Wang, Q., Wu, Z., Stevenson, S. C., Hild, M., Garza, D., & Li, H. (2007) · Genome Research · doi:10.1101/gr.6940108 · Cited by 65
“In Drosophila, only five HDACs were found for Class I and Class II, with”
BackgroundInfluential
Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer
Pulya, S., Himaja, A., Paul, M., Adhikari, N., Banerjee, S., Routholla, G., Biswas, S., Jha, T., & Ghosh, B. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00614 · Cited by 63
Azetidinones as Zinc‐Binding Groups to Design Selective HDAC8 Inhibitors
Galletti, P., Quintavalla, A., Ventrici, C., Giannini, G., Cabri, W., Penco, S., Gallo, G., Vincenti, S., & Giacomini, D. (2009) · ChemMedChem · doi:10.1002/cmdc.200900309 · Cited by 63
A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3–Specific CAR T Cells in Solid Tumors
Lei, X., Ou, Z., Yang, Z., Zhong, J., Zhu, Y., Tian, J., Wu, J., Deng, H., Lin, X., Yu, P., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2487 · Cited by 64
Total Synthesis of the Bicyclic Depsipeptide HDAC Inhibitors Spiruchostatins A and B, 5′′‐epi‐Spiruchostatin B, FK228 (FR901228) and Preliminary Evaluation of Their Biological Activity
Narita, K., Kikuchi, T., Watanabe, K., Takizawa, T., Oguchi, T., Kudo, K., 松原圭介, Abe, H., Yamori, T., Yoshida, M., et al. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200901552 · Cited by 61
Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer’s Disease
Mahady, L. J., Nadeem, M., Malek‐Ahmadi, M. H., Chen, K., Perez, S. E., & Mufson, E. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171032 · Cited by 61
Retracted: HDAC 1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways
Fan, C., Pan, Y., Yang, Y., Di, S., Jiang, S., Ma, Z., Li, T. X., Zhang, Z., Li, W., Li, X., et al. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12261 · Cited by 59
Retracted
Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors
Melagraki, G., Afantitis, A., Sarimveis, H., Koutentis, P. A., Kollias, G. A., & Igglessi‐Markopoulou, O. (2009) · Molecular Diversity · doi:10.1007/s11030-009-9115-2 · Cited by 60
Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer
Sarvari, P., Sarvari, P., Ramírez‐Díaz, I., Mahjoubi, F., & Rubio, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179521 · Cited by 68
Harnessing the cyclization strategy for new drug discovery
Tang, K., Wang, S., Gao, W., Song, Y., & Yu, B. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.09.022 · Cited by 59
Keep it in the subfamily: the conserved alphaherpesvirus US3 protein kinase
Deruelle, M., & Favoreel, H. W. (2010) · Journal of General Virology · doi:10.1099/vir.0.025593-0 · Cited by 57
Preclinical anti‐myeloma activity of the novel HDAC‐inhibitor JNJ‐26481585
Stühmer, T., Arts, J., Chatterjee, M., Borawski, J. M., Wolff, A., King, P., Einsele, H., Leo, E., & Bargou, R. C. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08126.x · Cited by 55
Hyperphosphorylation of Histone Deacetylase 2 by Alphaherpesvirus US3 Kinases
Walters, M. S., Kinchington, P. R., Banfield, B. W., & Silverstein, S. J. (2010) · Journal of Virology · doi:10.1128/jvi.00981-10 · Cited by 55
“activity (18), suggests that targeting these sites may have a”
Background
Surviving lethal septic shock without fluid resuscitation in a rodent model
Li, Y., Liu, B., Fukudome, E. Y., Kochanek, A. R., Finkelstein, R. A., Chong, W., Jin, G., Lu, J., DeMoya, M. A., Velmahos, G. C., et al. (2010) · Surgery · doi:10.1016/j.surg.2010.05.003 · Cited by 55
NMR Profiling of Histone Deacetylase and Acetyl-transferase Activities in Real Time
Dose, A., Liokatis, S., Theillet, F., Selenko, P., & Schwarzer, D. (2011) · ACS Chemical Biology · doi:10.1021/cb1003866 · Cited by 56
Chemical Probes Reveal Sirt2’s New Function as a Robust “Eraser” of Lysine Lipoylation
Xie, Y., Chen, L., Wang, R. Y., Wang, J., Li, J., Xu, W., Li, Y., Yao, S. Q., Zhang, L. N., Hao, Q., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b06913 · Cited by 55
Histone deacetylase 1 and 2 drive differentiation and fusion of progenitor cells in human placental trophoblasts
Bhattad, G. J., Jeyarajah, M. J., McGill, M. G., Dumeaux, V., Okae, H., Arima, T., Lajoie, P., Bérubé, N. G., & Renaud, S. J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2500-6 · Cited by 53
Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy
Yang, J., Grafton, F., Ranjbarvaziri, S., Budan, A., Farshidfar, F., Cho, M., Xu, E., Ho, J. J., Maddah, M., Loewke, K. E., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl5654 · Cited by 56
Black Raspberries Protectively Regulate Methylation of Wnt Pathway Genes in Precancerous Colon Tissue
Wang, L.-S., Kuo, C.-T., Huang, T. H. ‐., Yearsley, M., Oshima, K., Stoner, G. D., Yu, J., Lechner, J. F., & Huang, Y. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0077 · Cited by 53
Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer
Yan, Y., An, J., Yang, Y., Wu, D., Bai, Y., Cao, W., Ma, L., Chen, J., Yu, Z., He, Y., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708478 · Cited by 53
“In humans, there are 18 HDAC proteins categorized into four distinct classes (I, II, III, and IV) according to their homology to yeast proteins, subcellular location, and enzymatic activities (de Ruijter et al , 2003; Gallinari et al , 2007).”
The Antiparasitic Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase Activity
Cao, B., Li, J., Zhu, J., Shen, M., Han, K., Zhang, Z., Yu, Y., Wang, Y., Wu, D., Chen, S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.472563 · Cited by 52
Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity
Kang, K. A., Piao, M. J., Kim, K. C., Zheng, J., Yao, C. W., CHA, J. W., Kim, H. S., Kim, D. H., Bae, S. C., & Hyun, J. W. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2129 · Cited by 51
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B‐chronic lymphocytic leukaemia cells
Bouzar, A. B., Boxus, M., Defoiche, J., Berchem, G., Macallan, D. C., Pettengell, R., Willis, F. M., Burny, A., Lagneaux, L., Bron, D., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07426.x · Cited by 51
“…cell cultures of primary leukemic cells isolated from CLL patients, further extends the increasing list of evidence supporting the therapeutic potential of HDAC inhibitors, used alone or in combination with other cytotoxic drugs (Blaheta et al, 2002; Gallinari et al, 2007; Rasheed et al, 2007).”
Background
Mammalian SWI/SNF collaborates with a polycomb-associated protein to regulate male germline transcription in the mouse
Menon, D. U., Shibata, Y., Mu, W., & Magnuson, T. (2019) · Development · doi:10.1242/dev.174094 · Cited by 53
Whole-Genome Sequencing Analysis of Human Metabolome in Multi-Ethnic Populations
Feofanova, E. V., Brown, M. R., Alkis, T., Manuel, A. M., Li, X., Tahir, U. A., Li, Z., Mendez, K. M., Kelly, R. S., Qi, Q., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38800-2 · Cited by 49
“HDAC6 encodes histone deacetylase 6, a protein implicated in deacetylation of lysine residues on the N-terminal part of the core histones 23 .”
Genome-wide profiling identifies a subset of methamphetamine (METH)-induced genes associated with METH-induced increased H4K5Ac binding in the rat striatum
Cadet, J. L., Jayanthi, S., McCoy, M. T., Ladenheim, B., Saint-Preux, F., Lehrmann, E., De, S., Becker, K. G., & Brannock, C. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-545 · Cited by 50
Analysis of Human Colon by Raman Spectroscopy and Imaging-Elucidation of Biochemical Changes in Carcinogenesis
Brożek-Płuska, B., Musiał, J., Kordek, R., & Abramczyk, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143398 · Cited by 51
The Role of HDACs and HDACi in Cartilage and Osteoarthritis
Zhang, H., Ji, L., Yang, Y., Zhang, X., Gang, Y., & Bai, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.560117 · Cited by 49
Histone modifications: Targeting head and neck cancer stem cells
Le, J. M. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i5.511 · Cited by 49
Recent advances in histone deacetylase targeted cancer therapy
Hoshino, I., & Matsubara, H. (2010) · Surgery Today · doi:10.1007/s00595-010-4300-6 · Cited by 49
A Class 1 Histone Deacetylase with Potential as an Antifungal Target
Bauer, I., Varadarajan, D., Pidroni, A., Gross, S., Vergeiner, S., Faber, B., Hermann, M., Tribus, M., Brosch, G., & Graessle, S. (2016) · mBio · doi:10.1128/mbio.00831-16 · Cited by 49
“Because of their increasing importance as cytostatic agents that inhibit the proliferation of tumor cells, several potent HDACIs are currently in clinical trials or already FDA approved as therapy for speciﬁc types of cancer (55, 56).”
Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells
Okubo, K., Isono, M., Miyai, K., Asano, T., & Sato, A. (2019) · Cancer Science · doi:10.1111/cas.14225 · Cited by 49
Odd-chain fatty acids as novel histone deacetylase 6 (HDAC6) inhibitors
Ediriweera, M. K., To, N. B., Lim, Y., & Cho, S. K. (2021) · Biochimie · doi:10.1016/j.biochi.2021.04.011 · Cited by 49
Butyrate limits human natural killer cell effector function
Zaiatz-Bittencourt, V., Jones, F., Tosetto, M., Scaife, C., Cagney, G., Jones, E., Doherty, G. A., & Ryan, E. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-29731-5 · Cited by 49
Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival
Theocharis, S. E., Klijanienko, J., Giaginis, C., Rodriguez, J., Jouffroy, T., Girod, A., Alexandrou, P. T., & Sastre‐Garau, X. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01031.x · Cited by 49
Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties
Sun, P., Wang, J., Khan, K. S., Yang, W., Ng, W., Ilment, N. V., Zessin, M., Bülbül, E. F., Robaa, D., Erdmann, F., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01132 · Cited by 50
Energy based pharmacophore mapping of HDAC inhibitors against class I HDAC enzymes
Kalyaanamoorthy, S., & Chen, Y. P. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.08.009 · Cited by 47
A Bioluminogenic HDAC Activity Assay: Validation and Screening
Halley, F., Reinshagen, J., Ellinger, B., Wolf, M., Niles, A. L., Evans, N. J., Kirkland, T. A., Wagner, J. M., Jung, M., Gribbon, P. M., et al. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111416004 · Cited by 45
Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells
Liu, Z.-H., Li, J., Xia, J., Jiang, R., Zuo, G., Li, X.-P., Chen, Y., Xiong, W., & Chen, D. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.10.014 · Cited by 47
Inhibition of histone deacetylase 11 promotes human liver cancer cell apoptosis.
Gong, D., Zeng, Z., Yi, F., & Wu, J. (2019) · Europe PMC (PubMed Central) · Cited by 47
Dynamic Structure-Based Pharmacophore Model Development: A New and Effective Addition in the Histone Deacetylase 8 (HDAC8) Inhibitor Discovery
Thangapandian, S., John, S., Lee, Y., Kim, S., & Lee, K. W. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129440 · Cited by 47
Activatable Fluorescence Probe via Self-Immolative Intramolecular Cyclization for Histone Deacetylase Imaging in Live Cells and Tissues
Liu, X., Xiang, M., Tong, Z.-X., Luo, F.-Y., Chen, W., Liu, F., Wang, F., Yu, R., & Jiang, J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00709 · Cited by 47
HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages
Romani, B., Shaykh‐Baygloo, N., Hamidi-Fard, M., Aghasadeghi, M. R., & Allahbakhshi, E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.689018 · Cited by 47
SIRT1 activates the expression of fetal hemoglobin genes
Dai, Y., Chen, T., Ijaz, H., Cho, E. H., & Steinberg, M. H. (2017) · American Journal of Hematology · doi:10.1002/ajh.24879 · Cited by 47
An amber obligate active site-directed ligand evolution technique for phage display
Tharp, J. M., Hampton, J. T., Reed, C. A., Ehnbom, A., Chen, P. C., Morse, J. S., Kurra, Y., Pérez, L. M., Xu, S., & Liu, W. R. (2020) · Nature Communications · doi:10.1038/s41467-020-15057-7 · Cited by 46
Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions
Ser, M. H., Webb, M., Sener, U. T., & Campian, J. L. (2023) · Journal of Immunotherapy and Precision Oncology · doi:10.36401/jipo-23-34 · Cited by 51
“[107] Their inhibition is associated with the inhibition of cell proliferation, tumorolysis, and the induction of antitumor immune response, making them a promising option for improving ICI efficacy in GBM. [108] A clinical trial combining pembrolizumab with vorinostat, a histone deace-tylases…”
Background
Mitochondrial SIRT5 is present in follicular cells and is altered by reduced ovarian reserve and advanced maternal age
Pacella‐Ince, L., Zander‐Fox, D., & Lane, M. (2013) · Reproduction Fertility and Development · doi:10.1071/rd13178 · Cited by 46
KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo
Hassig, C. A., Symons, K. T., Guo, X., Nguyen, P.-M., Annable, T., Wash, P. L., Payne, J. E., Jenkins, D. A., Bonnefous, C., Trotter, C., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2347 · Cited by 44
“In tumor cells, HDACs are overexpressed or aberrantly recruited to regions of the genome that harbor tumor suppressor genes, resulting in their transcriptional down-regulation or silencing (3).”
Background
Epigenetic changes in cancer by Raman imaging, fluorescence imaging, AFM and scanning near-field optical microscopy (SNOM). Acetylation in normal and human cancer breast cells MCF10A, MCF7 and MDA-MB-231
Abramczyk, H., Surmacki, J. M., Kopeć, M., Olejnik, A. K., Kaufman‐Szymczyk, A., & Fabianowska‐Majewska, K. (2016) · The Analyst · doi:10.1039/c6an00859c · Cited by 44
Protein arginine methyltransferase 5 (PRMT5) activates WNT/β‐catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3
Shailesh, H., Siveen, K. S., & Sif, S. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16260 · Cited by 45
Epigenetics and its role in effecting agronomical traits
Gupta, C., & Salgotra, R. K. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.925688 · Cited by 43
“These counteract the effects of HATs resulting in gene repression (Gallinari et al., 2007; Gu et al., 2017; Yang et al., 2020).”
Background
Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins
Zhang, J., Gao, X., & Yu, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.741746 · Cited by 45
Reactive Oxygen Species–Mediated Synergism of Fenretinide and Romidepsin in Preclinical Models of T-cell Lymphoid Malignancies
Makena, M. R., Koneru, B., Nguyen, T. H., Kang, M. H., & Reynolds, C. P. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0749 · Cited by 44
“Histone deacetylases (HDAC) remove acetyl groups on histones, leading to a closed chromatin configuration and transcriptional repression (7).”
Background
In Silico Approaches for Investigating the Binding Propensity of Apigenin and Luteolin Against Class I HDAC Isoforms
Ganai, S. A., Farooq, Z., Banday, S., & Altaf, M. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0020 · Cited by 43
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
Nguyen, H.-M., & Saha, D. (2021) · Oncolytic Virotherapy · doi:10.2147/ov.s268426 · Cited by 44
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells
Dejligbjerg, M., Grauslund, M., Litman, T., Collins, L. S., Qian, X., Jeffers, M., Lichenstein, H. S., Jensen, P., & Sehested, M. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-70 · Cited by 45
Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression
Vinodhkumar, R., Song, Y., & Devaki, T. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.06.002 · Cited by 43
Gut microbial metabolite targets HDAC3-FOXK1-interferon axis in fibroblast-like synoviocytes to ameliorate rheumatoid arthritis
Chen, H., Fu, X., Wu, X., Zhao, J., Qiu, F., Wang, Z., Wang, Z., Chen, X., Xie, D., Huang, J., et al. (2024) · Bone Research · doi:10.1038/s41413-024-00336-6 · Cited by 47
“42 Studies have shown that HDAC3 can interact with RCAN1 and increase RCAN1 protein stability by inhibiting its poly-ubiquitination.”
Background
Development of a new diagnostic Raman method for monitoring epigenetic modifications in the cancer cells of human breast tissue
Brożek-Płuska, B., Kopeć, M., & Abramczyk, H. (2016) · Analytical Methods · doi:10.1039/c6ay02559e · Cited by 42
Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α
Biziotis, O., Tsakiridis, E. E., Ali, A., Ahmadi, E., Wu, J., Wang, S. J. H., Mekhaeil, B., Singh, K., Menjolian, G., Farrell, T. J., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13508 · Cited by 46
“They play global roles in regulating gene transcription, proliferation, and survival but are also notoriously overexpressed in solid malignancies [57].”
Background
Macrocyclic compounds as anti-cancer agents: Design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2
Ning, C., Lu, C., Hu, L., Bi, Y.-J., Yao, L., He, Y., Liu, L., Liu, X., & Yu, N. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.034 · Cited by 41
Histone Deacetylase Inhibitor Valproic Acid Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-Like Cells
Kondo, Y., Iwao, T., Yoshihashi, S., Mimori, K., Ogihara, R., Nagata, K., Kurose, K., Saito, M., Niwa, T., Suzuki, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104010 · Cited by 39
A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study
Choubey, S. K., & Jeyakanthan, J. (2016) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2016.09.008 · Cited by 39
“The parameter yi was calculated by using the formula: yro i = ki (6)”
Method
Zn2+-Dependent Histone Deacetylases in Plants: Structure and Evolution
Yruela, I., Moreno–Yruela, C., & Olsen, C. A. (2021) · Trends in Plant Science · doi:10.1016/j.tplants.2020.12.011 · Cited by 40
Loss of Histone Deacetylase 4 Causes Segregation Defects during Mitosis of p53-Deficient Human Tumor Cells
Cadot, B., Brunetti, M., Coppari, S., Fedeli, S., de Rinaldis, E., Russo, C. D., Gallinari, P., Francesco, R. D., Steinkühler, C., & Filocamo, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2796 · Cited by 41
Self-citation
Genetic Modulation of Rpd3 Expression Impairs Long-Term Courtship Memory in Drosophila
Fitzsimons, H. L., & Scott, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029171 · Cited by 45
“HDACs are highly conserved across species and the Drosophila genome contains five zinc-dependent HDACs: Rpd3, HDAC3, HDAC4, HDAC6 and HDAC11 [31].”
Background
Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors: Part II
Lee, C., Choi, E., Cho, M., Lee, B., Oh, S. J., Park, S.-K., Lee, K., Kim, H. M., & Han, G. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.045 · Cited by 41
Clinical efficacy and mechanistic insights of FDA-approved HDAC inhibitors in the treatment of lymphoma
Omari, N. E., Bakrim, S., Elhrech, H., Aanniz, T., Balahbib, A., Lee, L., Abdulmonem, W. A., & Bouyahya, A. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107057 · Cited by 44
Histone deacetylases control module-specific phenotypic plasticity in beetle weapons
Ozawa, T., Mizuhara, T., Arata, M., Shimada, M., Niimi, T., Okada, K., Okada, Y., & Ohta, K. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615688114 · Cited by 40
Chimeric Peptides Self-Assembling on Titanium Carbide MXenes as Biosensing Interfaces for Activity Assay of Post-translational Modification Enzymes
Wang, S., Zeng, P., Zhu, X., Lei, C., Huang, Y., & Nie, Z. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00243 · Cited by 40
Plasmodium falciparum: new molecular targets with potential for antimalarial drug development
Gardiner, D. L., Skinner‐Adams, T. S., Brown, C. L., Andrews, K. T., Stack, C. M., McCarthy, J. S., Dalton, J. P., & Trenholme, K. R. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.93 · Cited by 40
Genetic variants in the SWI/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population
Zhu, B., Tian, J., Zhong, R., Tian, Y., Chen, W., Qian, J., Zou, L., Xiao, M., Shen, N., Yang, H. B., et al. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22140 · Cited by 39
Structural and functional implications of phosphorylation and acetylation in the regulation of the AAA+ protein p97This paper is one of a selection of papers published in this special issue entitled 8th International Conference on AAA Proteins and has undergone the Journal's usual peer review process.
Ewens, C. A., Kloppsteck, P., Förster, A., Zhang, X., & Freemont, P. S. (2010) · Biochemistry and Cell Biology · doi:10.1139/o09-128 · Cited by 39
The B7 Family Member B7-H6: a New Bane of Tumor
Chen, Y., Mo, J., Jia, X., & He, Y. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0357-5 · Cited by 39
Characterization of the regulation and function of zinc-dependent histone deacetylases during rodent liver regeneration
Huang, J., Barr, E., & Rudnick, D. A. (2012) · Hepatology · doi:10.1002/hep.26206 · Cited by 37
Oncogenic potential of CK 2α and its regulatory role in EGF ‐induced HDAC 2 expression in human liver cancer
Kim, H. S., Chang, Y. G., Bae, H. J., Eun, J. W., Shen, Q., Park, S. J., Shin, W. C., Lee, E. K., Park, S., Ahn, Y. M., et al. (2013) · FEBS Journal · doi:10.1111/febs.12652 · Cited by 37
Epigenetic mechanisms in chronic obstructive pulmonary disease.
Dd, Z., Ry, O., & Chen, P. (2015) · PubMed · Cited by 37
Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma
SPARTALIS, E., ATHANASIADIS, D. I., CHRYSIKOS, D., SPARTALIS, M., BOUTZIOS, G., SCHIZAS, D., GARMPIS, N., DAMASKOS, C., PASCHOU, S. A., IOANNIDIS, A., et al. (2019) · Anticancer Research · doi:10.21873/anticanres.13220 · Cited by 34
Histone Deacetylase 3 Unconventional Splicing Mediates Endothelial-to-mesenchymal Transition through Transforming Growth Factor β2
Zeng, L., Wang, G., Ummarino, D., Margariti, A., Xu, Q., Xiao, Q., Wang, W., Zhang, Z., Yin, X., Mayr, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463745 · Cited by 36
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial
Shi, W., Lawrence, Y. R., Choy, H., Werner‐Wasik, M., Andrews, D. W., Evans, J. J., Judy, K. D., Farrell, C. J., Moshel, Y. A., Berger, A. C., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1433-2 · Cited by 36
Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer
Stettner, M., Krämer, G., Strauß, A., Kvitkina, T., Ohle, S., Kieseier, B. C., & Thelen, P. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32834a7e6f · Cited by 36
“Considering the fact that the molecular mechanism of HDACi drugs to rectify gene expression is mainly limited to aberrantly altered genes and thus to cancer or precancer cells, this is not surprising (Lindemann et al., 2004; Gallinari et al., 2007).”
Background
Epigenetics: tools and technologies
Janzen, W. P., Wigle, T. J., Jin, J. J., & Frye, S. V. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.07.004 · Cited by 38
Hierarchical virtual screening of the dual MMP-2/HDAC-6 inhibitors from natural products based on pharmacophore models and molecular docking
Wang, Y., Yang, L.-M. C., Hou, J., Zou, Q. S., Gao, Q., Yao, W., Yao, Q., & Zhang, J. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1434833 · Cited by 35
Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension
Kee, H. J., Kim, I., & Jeong, M. H. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115111 · Cited by 38
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias
D’Amato, L., Dell’Aversana, C., Conte, M., Ciotta, A., Scisciola, L., Carissimo, A., Nebbioso, A., & Altucci, L. (2014) · Epigenetics · doi:10.4161/15592294.2014.988035 · Cited by 34
“and survival controllers.(16) Histone hyperacetylation activates tumor-suppressor genes (TSG) and represses oncogenes, restoring the normal cell state.”
Background
Cell-specific expression of aquaporin-5 (Aqp5) in alveolar epithelium is directed by GATA6/Sp1 via histone acetylation
Flodby, P., Li, C., Liu, Y., Wang, H., Rieger, M. E., Minoo, P., Crandall, E. D., Ann, D. K., Borok, Z., & Zhou, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-03152-7 · Cited by 34
Naturally Occurring Regulators of Histone Acetylation/Deacetylation
Folmer, F., Orlikova, B., Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2010) · Current Nutrition & Food Science · doi:10.2174/157340110790909581 · Cited by 35
Regulation of Thermogenic Adipocyte Differentiation and Adaptive Thermogenesis Through Histone Acetylation
Ong, B. X., Brunmeir, R., Zhang, Q., Xu, P., Idris, M., Liu, C., & Xu, F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00095 · Cited by 33
Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90)
Bonanni, D., Citarella, A., Moi, D., Pinzi, L., Bergamini, E., & Rastelli, G. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210902145102 · Cited by 33
Epigenetic Modulation with HDAC Inhibitor CG200745 Induces Anti-Proliferation in Non-Small Cell Lung Cancer Cells
Chun, S., Lee, J., Choi, J., Lee, J., Hwang, J. J., Kim, C.-S., Suh, Y., & Jang, S. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119379 · Cited by 36
Epigenetics in Asthma and Other Inflammatory Lung Diseases
Durham, A. L., Chou, P.-C., Kirkham, P., & Adcock, I. M. (2010) · Epigenomics · doi:10.2217/epi.10.27 · Cited by 34
Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma
Wang, L., Chiou, S., Chai, C., Hsi, E., Wang, S., Huang, S.-K., & Hsu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.9841 · Cited by 33
“In humans, HDACs are grouped in four classes of proteins: class I, IIa, IIb, III, and IV [15–17].”
Background
A steered molecular dynamics mediated hit discovery for histone deacetylases
Kalyaanamoorthy, S., & Chen, Y. P. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp53511h · Cited by 32
Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities
Ghith, A., Ismail, N. S. M., Youssef, K. M., & Abouzid, K. A. M. (2017) · Archiv der Pharmazie · doi:10.1002/ardp.201700242 · Cited by 32
Synthesis and biological evaluation of novel quinolone derivatives dual targeting histone deacetylase and tubulin polymerization as antiproliferative agents
Wang, X., Jiang, X., Sun, S., & Liu, Y. (2018) · RSC Advances · doi:10.1039/c8ra02578a · Cited by 32
MRE11 as a molecular signature and therapeutic target for cancer treatment with radiotherapy
Wang, Y., Hung, A. C., Lo, S. J., Hsieh, Y.-C., & Yuan, S. F. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.013 · Cited by 33
Epigenetics of Triple-Negative Breast Cancer via Natural Compounds
Kaleem, M., Perwaiz, M., Nur, S. M., Abdulrahman, A. O., Ahmad, W., Al-Abbasi, F. A., Kumar, V., Kamal, M. A., & Anwar, F. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210707165530 · Cited by 34
N-acetyl l-aspartate and Triacetin modulate tumor suppressor MicroRNA and class I and II HDAC gene expression induce apoptosis in Glioblastoma cancer cells in vitro
Ramaiah, M. J., Kurappalli, R. K., Ramalingam, P. S., & Moparthi, N. R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120024 · Cited by 32
A regulatory circuit comprising the CBP and SIRT7 regulates FAM134B-mediated ER-phagy
Wang, X., Jiang, X. M., Li, B., Zheng, J., Guo, J., Gao, L., Du, M., Weng, X., Li, L., Chen, S., et al. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202201068 · Cited by 29
“Acetyltransferases and deacetylases control the homeostasis of protein acetylation, and the latter consists of HDAC and the Sirtuin (SIRT) family deacetylases (Drazic et al., 2016; Gallinari et al., 2007).”
Background
Gut health and serum growth hormone levels of broiler chickens fed dietary chitin and chitosan from cricket and shrimp
Ibitoye, E. B., Lokman, I. H., Hezmee, M. N. M., Goh, Y. M., Zuki, A. B. Z., Jimoh, A. A., Danmaigoro, A., & Nicholas, N. P. (2018) · Poultry Science · doi:10.3382/ps/pey419 · Cited by 31
“tion is known to increase mRNA expression (Gallinari et al., 2007).”
Background

Authors: Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C.
Affiliations: Institute of Molecular Biology and Pathology (IT)
Corresponding author: Steinkühler, Christian
ORCID: Gallinari, Paola
Steinkühler, Christian
Venue: Cell Research
Publisher: Springer Science and Business Media LLC
Published: 2007-02-27
Volume: 17
Issue: 3
Pages: 195-211
ISSN: 1001-0602 (ISSN-L)
1748-7838
DOI: 10.1038/sj.cr.7310149
OpenAlex: W2031954417
Semantic Scholar: 755cb3e836171a20f267d47b6677a035efcf7c22
Cited by: 678
References: 165
Citations by year: 2026: 47 · 2025: 87 · 2024: 38 · 2023: 37 · 2022: 52 · 2021: 58 · 2020: 30 · 2019: 29 · 2018: 28 · 2017: 20 · 2016: 29 · 2015: 22 · 2014: 27 · 2013: 38 · 2012: 20
FWCI: 2.44
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Cell Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords: histone deacetylase, histone acetyltransferase, histone acetylation, gene transcription, chromatin conformation, histone deacetylase inhibitors, cancer therapeutics, non-histone protein acetylation, post-translational modification, cell cycle regulation, cell differentiation, malignant transformation
MeSH terms: Acetylation, Animals, Histone Deacetylases, Histones, Humans, Models, Biological, Models, Molecular, Molecular Biology, Neoplasms, Transcription, Genetic, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks